CLINICAL_TRIALS
trial_result
· 2023-09-06
Clinical Trial Update: Evaluate the Efficacy and Safety of DWJ108J [Phase 3]
Summary
A Phase 3 clinical trial update for DWJ108J in Central Precocious Puberty is listed, with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Central Precocious Puberty | Phase 3 | Status: UNKNOWN